Showing results (81-90 of 86) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 19, 2008
Metabolism and disposition of dasatinib after oral administration to humansLisa J Christopher, Donghui Cui, Chiyuan Wu, et al.Cell Death & Disease|November 9, 2013
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)R Y-J Huang, M K Wong, T Z Tan, et al.Blood|May 15, 2008
Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemiaKimmo Porkka, Perttu Koskenvesa, Tuija Lundán, et al.Science Advances|February 26, 2019
Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapyMegan M Tu, Francis Y F Lee, Robert T Jones, et al.British Journal of Cancer|December 24, 2010
Replication study of SNP associations for colorectal cancer in Hong Kong ChineseJ W Ho, S-c Choi, Y-f Lee, et al.Journal of Medicinal Chemistry|March 19, 2004
N-(cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agentRaj N Misra, Hai-yun Xiao, Kyoung S Kim, et al.Pageof 9